We additionally attempted to detect this novel E-selectin ligand within total CD45 immunopurified from peripheral blood mononuclear cells (PBMCs) of patients with AML with varying levels of peripheral blood AML blast burden and, also, from the human CD34–negative AML cell line U937. Here, SELE is linked to acute myeloid leukemia.